Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

152.77
Delayed Data
As of May 25
 +1.08 / +0.71%
Today’s Change
108.50
Today|||52-Week Range
194.73
+8.69%
Year-to-Date
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close151.69
Today’s open151.50
Day’s range150.69 - 154.30
Volume458,146
Average volume (3 months)732,980
Market cap$9.2B
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+18.23%
Earnings growth (next 5 years)+15.50%
Revenue growth (last year)+12.95%
P/E ratio28.9
Price/Sales6.69
Price/Book5.82

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+1.01+3.87%
MDVNMedivation Inc-0.43-0.69%
IDXXIDEXX Laboratories I...-0.14-0.16%
RDYDr.Reddy's Laborator...+0.92+2.06%
Data as of 05/25/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.76
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs